Abstract:Objective:The aim of this study was to investigate clinical factors related to early pregnancy loss after in vitro fertilization and embryo transfer (IVF-ET) treatment,with the aim of providing future guidance and treatment.Results:Infertility due to the male partner was significantly higher in the pregnancy loss group than in the full-term pregnancy group (32.7％ vs.15.9％,P＜0.05) while tubal factor was found to be lower in the pregnancy loss group than in the full-term pregnancy group (54.5％ vs.79.3％,P＜0.05).More women were found to have PCOS in the pregnancy loss group than in the full-term pregnancy group,although this was not found to be statistically significant (P=0.06).The the ratio of basal follicle stimulating hormone (FSH) /basal LH in the full-term pregnancy group were significantly lower than in the pregnancy loss group (2.0 ±0.11 IU/L and 2.6 ±0.21 IU/L,respectively,P＜0.05).The dose of gonadotropin used in the pregnancy loss group was higher than that in the full term pregnancy group (2775 ±120 vs.2295 ±150 IU,P＜0.05).The number of embryos available for transfer and the total number of top quality embryos were lower in the pregnancy loss group than in the full-term pregnancy group (P＜0.05).Conclusions:Patients in the pregnancy loss group were more likely to experience ovarian dysfunction and have poor quality embryos.The male partner and PCOS affected the quality of sperms and eggs,respectively.Assisted reproductive technology cannot compensate for these inferior factors.These adverse factors should be reduced via pretreatment prior to IVF-ET to increase the live birth rate.

M005 ANALYSIS OF CLINICAL FACTORS ON PREGNANCY LOSS DURING IVF‐ET TREATMENT